The mechanisms of resistance to inhibition of the BRAF signaling pathway have been elucidated by the metabolic plasticity of melanoma and reprogramming from glycolysis to mitochondrial metabolism [5,6,7,8]. The gene discussed is BRAF; the disease is melanoma.